The company said revenue for Q3 2024 rose to $976 million, up 7% as reported and 6% organic, and diluted earnings per share (EPS) were $2.80, up 11% as reported and 12% on a comparable basis.

1. 01

   The company said revenue for Q3 2024 rose to $976 million, up 7% as reported and 6% organic, and diluted earnings per share (EPS) were $2.80, up 11% as reported and 12% on a comparable basis.

2. 02

   IDEXX said gross margin for Q3 was 61.1%, up 120 basis points as reported, and operating margin was 31.2%, up 110 basis points as reported and 100 basis points on a comparable basis.

3. 03

   The company cut its full-year 2024 revenue outlook to $3,865 million to $3,890 million, a reduction of $38 million at the midpoint, from a prior outlook of $3,885 million to $3,945 million.

4. 04

   The company narrowed its full-year 2024 EPS outlook range to $10.37 to $10.53 and kept the midpoint unchanged from the prior range of $10.31 to $10.59.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.